AstraZeneca India appoints Bhavana Agrawal as Chief Financial Officer

31 May 2023 | News

Her last role was as CFO of the Services business at GE Healthcare

AstraZeneca Pharma India has announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the Company from the close of business hours on September 30, 2023.

Marwaha has been instrumental in building strategic frameworks for the company in India in tandem with the evolving environment of pharmaceutical sector in the country. As a board member, he has also been a strong anchor behind key initiatives focused on improving access to healthcare. 

An All‐India rank holder as a Chartered Accountant, Bhavana has been a strategic finance partner for businesses with consistent performance in maximising revenue, margin and cash for over two decades. Her last role was as CFO of the Services business at GE Healthcare for Middle East, Africa & Russia, where she was responsible for revenue, costs, cash, planning session and financial closing activities in more than 30 countries. At AstraZeneca India, Bhavana will oversee company's financial strategy and operations, planning and analysis, and investor relations.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account